Personalis KSU | The Sentinel Newspaper / Apr 7, 2021
Want to see the real deal?
More inside scoop? View in App
More inside scoop? View in App
FOLLOWING
Show more
Personalis News
KSU | The Sentinel Newspaper
Personalis MarketBeat / Apr 6, 2021
Personalis, Inc. (NASDAQ:PSNL) insider Richard Chen sold 40,000 shares of the stock in a transaction dated Thursday, April 1st. The shares were sold at an average price of $25.69, for a total value of $1,027,600.00. Following the completion of the transaction, the insider now directly owns 62,094 shares of the company's stock, valued at approximately $1,595,194.86.
MarketBeat
Personalis The Bisouv Network / Apr 6, 2021
In the latest Research Report on "Global Cancer Immunotherapy Drug Discovery Outsourcing Market" offers an Exclusive Research analysis of the present scenario of the global market. This report contains market revenue, sales, Cancer Immunotherapy Drug Discovery Outsourcing production and manufacturing cost that could help you to get a better view on the market.
Personalis FLA News / Apr 6, 2021
United States of America:- The Genomic Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
FLA News
Personalis InvestorsObserver / Apr 5, 2021
Personalis Inc ( PSNL) stock is higher by 15.71% over the past week and gets a Neutral rating from InvestorsObserver's Sentiment Indicator. Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company.
Personalis RealMoney / Apr 5, 2021
We are off to a strong start Monday morning on better than 2 to 1 positive breadth. Although bonds ( TLT) are weaker this morning, it isn't a problem for buyers so far. It is likely that concern about higher rates and inflation is creating a Wall of Worry dynamic for the market.
Personalis Simply Wall St / Apr 5, 2021
Just because a business does not make any money, does not mean that the stock will go down. For example, Personalis ( NASDAQ:PSNL) shareholders have done very well over the last year, with the share price soaring by 215%. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com?
Personalis MarketBeat / Apr 2, 2021
Personalis, Inc. (NASDAQ:PSNL) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 3,060,000 shares, an increase of 34.2% from the February 28th total of 2,280,000 shares. Based on an average daily volume of 1,100,000 shares, the short-interest ratio is presently 2.8 days.
Personalis KSU | The Sentinel Newspaper / Apr 2, 2021
The Gene Panel Market is expected to grow at a CAGR of 7.9% and is poised to reach US$XX Billion by 2027 as compared to US$XX Billion in 2020. The factors leading to this extraordinary growth is attributed to various market dynamics discussed in the report Our experts have examined the market from a 360 degree perspective thereby producing a report which is definitely going to impact your business decisions.
Personalis Yahoo Finance / Apr 1, 2021
Personalis (PSNL) shares ended the last trading session 7.9% higher at $24.61. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 26.3% loss over the past four weeks.
Personalis Fractovia News / Mar 31, 2021
Personalis Inc., a US-based cancer genomics company has announced to have signed a joint venture agreement with MapKure, LLC, a newly created entity owned by SpringWorks and BeiGene, that focuses solely on genetic disease drivers.
Fractovia News
Personalis Analyst Ratings / Mar 31, 2021
By Austin Angelo There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on IGM Biosciences ( IGMS - Research Report), Personalis ( PSNL - Research Report) and Crinetics Pharmaceuticals ( CRNX - Research Report) with bullish sentiments. IGM Biosciences (IGMS) H.C.
.jpg)
Analyst Ratings
Personalis RealMoney / Mar 31, 2021
We have a mild but positive start to the day as some rotational action has finally cooled off, and mark-ups into the first quarter's close are stepping up. Breadth is healthy with 5300 gainers to 2100 losers, but pockets of momentum are still quite slim, and there are only 160 names hitting new 12-month highs.
Personalis GlobeNewswire / Mar 31, 2021
Led investments for several clinical-stage companies as a Partner at Sofinnova Investments LAUSANNE, Switzerland, March 31, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that Alan Colowick, MD, MPH, a deeply experienced biotech and investment executive, was elected to the Company's Board of Directors at an extraordinary shareholders' meeting today.
GlobeNewswire
Personalis Fairfield Mirror / Mar 31, 2021
Today, March 31, marks the end of the annual month-long celebration of women's incredible impact on our world and society. March is Women's History Month, it's the time when we celebrate amazing leaders such as Malala Yousafzai, Amelia Earhart, Rosa Parks, Greta Thunberg and Michelle Obama, to name a few.
50 Years of Women at Fairfield: What Progress Has Been Made?
Fairfield Mirror
Personalis GenomeWeb / Mar 30, 2021
NEW YORK - MapKure announced a partnership with Personalis on Monday to use its NGS assay, the NeXT Platform, to screen patients for a Phase I clinical trial of its BRAF inhibitor, BGB-3245.
Personalis InvestorsObserver / Mar 30, 2021
Analysts who follow Personalis Inc (PSNL) on average expect it to add 73.42% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns PSNL an Analyst Ranking of 55, which means it ranks
Analyst Rating: Will Personalis Inc (PSNL) Stock Outperform the Market?
InvestorsObserver
Personalis The Sentinel / Mar 30, 2021
Rockhurst University began the remodeling of the first building on campus, Sedgwick Hall. The history of Rockhurst lies between the walls of Sedgwick Hall. The building stood untouched for 107 years and holds a great meaning to the campus. The reconstruction of Sedgwick Hall caught the eye of many students and staff, as they were...
Sedgwick Hall: New and Improved – The Sentinel
The Sentinel
Personalis RealMoney / Mar 30, 2021
The Dow Jones industrial average, S&P 500, and Nasdaq all lost some ground Tuesday, but breadth improved with 5,000 gainers to 3,100 decliners as the selling pressure on small-cap stocks finally relented. It was not an energetic snap-back rally for the Russell 2000 ( IWM) , but at least there was a little more action for stock pickers.
Personalis KSU | The Sentinel Newspaper / Mar 30, 2021
